| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |